ZYUS Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May '26 May 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	40	70	64	33	6	9
Market Cap Growth	-31.28%	9.62%	94.67%	477.81%	-35.56%	50.00%
Enterprise Value	54.65	79.75	67.31	67.11	-2.92	0.35
Last Close Price	0.50	0.94	0.90	0.85	1.16	1.80
PE Ratio	-	-	-	-	16.57	-
PS Ratio	85.72	145.32	181.66	109.91	-	35611.50
PB Ratio	-3.07	-13.08	2.76	6.91	0.66	1.07
P/TBV Ratio	-2.88	-12.68	2.19	6.90	0.68	1.11
EV/Sales Ratio	117.52	165.80	191.77	225.22	-	1403.34
EV/EBITDA Ratio	-	-	-	-	-	545.87
EV/EBIT Ratio	-	-	-	-	-	545.87
EV/FCF Ratio	-	-	-	-	8.77	-
Debt / Equity Ratio	-1.14	-2.20	0.41	7.29	0	0
Net Debt / Equity Ratio	-1.14	-1.92	0.17	7.32	-1.01	-1.03
Net Debt / EBITDA Ratio	-0.48	-0.32	-0.10	-2.35	-	-13306.17
Net Debt / FCF Ratio	-1.17	-1.03	-0.22	-3.42	25.78	389.64
Asset Turnover	0.04	0.02	0.01	0.01	0	0.00
Inventory Turnover	0.44	0.15	0.05	0.05	-	-
Quick Ratio	0.05	0.13	0.49	0.03	89.74	26.70
Current Ratio	0.10	0.19	0.71	0.44	89.74	26.70
Return on Equity (ROE)	368.55%	-380.47%	-305.81%	-371.31%	4.19%	-8.52%
Return on Assets (ROA)	-250.70%	-117.07%	-69.69%	-51.12%	0.00%	0.01%
Return on Invested Capital (ROIC)	-949.87%	-193.87%	-92.01%	-72.94%	0.00%	-0.26%
Return on Capital Employed (ROCE)	899.10%	-272.58%	-106.92%	-63.72%	0.00%	0.01%
Earnings Yield	-	-	-	-	6.03%	-
Buyback Yield / Dilution	-6.48%	-28.41%	-45.82%	-665.26%	0.00%	0.00%
Total Shareholder Return	-6.48%	-28.41%	-45.82%	-665.26%	0.00%	0.00%